Literature DB >> 16973549

Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.

R Feederle1, B Neuhierl, G Baldwin, H Bannert, B Hub, J Mautner, U Behrends, H J Delecluse.   

Abstract

Epstein-Barr virus (EBV) is a tumor virus with marked B lymphotropism. After crossing the B-cell membrane, the virus enters cytoplasmic vesicles, where decapsidation takes place to allow transfer of the viral DNA to the cell nucleus. BNRF1 has been characterized as the EBV major tegument protein, but its precise function is unknown. We have constructed a viral mutant that lacks the BNRF1 gene and report here its in vitro phenotype. A recombinant virus devoid of BNRF1 (DeltaBNRF1) showed efficient DNA replication and production of mature viral particles. B cells infected with the DeltaBNRF1 mutant presented viral lytic antigens as efficiently as B cells infected with wild-type or BNRF1 trans-complemented DeltaBNRF1 viruses. Antigen presentation in B cells infected with either wild-type (EBV-wt) or DeltaBNRF1 virus was blocked by leupeptin addition, showing that both viruses reach the endosome/lysosome compartment. These data were confirmed by direct observation of the mutant virus in endosomes of infected B cells by electron microscopy. However, we observed a 20-fold reduction in the number of B cells expressing the nuclear protein EBNA2 after infection with a DeltaBNRF1 virus compared to wild-type infection. Likewise, DeltaBNRF1 viruses transformed primary B cells much less efficiently than EBV-wt or BNRF1 trans-complemented viruses. We conclude from these findings that BNRF1 plays an important role in viral transport from the endosomes to the nucleus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973549      PMCID: PMC1617231          DOI: 10.1128/JVI.00473-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Epstein-Barr virus enters B cells and epithelial cells by different routes.

Authors:  N Miller; L M Hutt-Fletcher
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Replication of Epstein-Barr virus: ultrastructural and immunofluorescent studies of P3HR1-superinfected Raji cells.

Authors:  J M Seigneurin; M Vuillaume; G Lenoir; G De-Thé
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

3.  Herpes simplex virus virion host shutoff function.

Authors:  A D Kwong; J A Kruper; N Frenkel
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

Authors:  M E Campbell; J W Palfreyman; C M Preston
Journal:  J Mol Biol       Date:  1984-11-25       Impact factor: 5.469

5.  Sequence complexity of circular Epstein-Bar virus DNA in transformed cells.

Authors:  B E Griffin; E Björck; G Bjursell; T Lindahl
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

6.  Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process.

Authors:  G R Nemerow; N R Cooper
Journal:  Virology       Date:  1984-01-15       Impact factor: 3.616

7.  The 160,000-Mr virion protein encoded at the right end of the herpesvirus saimiri genome is homologous to the 140,000-Mr membrane antigen encoded at the left end of the Epstein-Barr virus genome.

Authors:  K R Cameron; T Stamminger; M Craxton; W Bodemer; R W Honess; B Fleckenstein
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

8.  Chemical cross-linking of virion envelope and tegument proteins of herpes simplex virus type 1.

Authors:  Q Zhu; R J Courtney
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

9.  Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.

Authors:  B Kempkes; D Pich; R Zeidler; B Sugden; W Hammerschmidt
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs.

Authors:  C A Smibert; B Popova; P Xiao; J P Capone; J R Smiley
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  30 in total

1.  Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell response.

Authors:  Bernhard Neuhierl; Regina Feederle; Dinesh Adhikary; Birgit Hub; Karsten Geletneky; Josef Mautner; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

2.  The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication.

Authors:  R Feederle; H Bannert; H Lips; N Müller-Lantzsch; H-J Delecluse
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

Review 3.  Virion factors that target Daxx to overcome intrinsic immunity.

Authors:  Sabrina Schreiner; Harald Wodrich
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

4.  The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production.

Authors:  Regina Feederle; Anja M Mehl-Lautscham; Helmut Bannert; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

5.  An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA.

Authors:  Sophia Pavlova; Regina Feederle; Kathrin Gärtner; Walter Fuchs; Harald Granzow; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

6.  Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection.

Authors:  Kevin Tsai; Lilian Chan; Rebecca Gibeault; Kristen Conn; Jayaraju Dheekollu; John Domsic; Ronen Marmorstein; Luis M Schang; Paul M Lieberman
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

7.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

8.  Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles.

Authors:  Marisa Granato; Regina Feederle; Antonella Farina; Roberta Gonnella; Roberta Santarelli; Birgit Hub; Alberto Faggioni; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

Review 9.  Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme.

Authors:  Kevin Tsai; Troy E Messick; Paul M Lieberman
Journal:  Curr Opin Virol       Date:  2015-08-07       Impact factor: 7.090

10.  Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles.

Authors:  Dinesh Adhikary; Uta Behrends; Regina Feederle; Henri-Jacques Delecluse; Josef Mautner
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.